Jing Zhang; Jinxueyue Chen; Hui Feng; Ying Hong; Jing Zhao; Xiaohua Pan; Yan Chen; Jian Zhao; Yan Zhang; Jing Zhang; Jinxueyue Chen; Hui Feng; Ying Hong; Jing Zhao; Xiaohua Pan; Yan Chen; Jian Zhao; Yan Zhang

doi:10.46234/ccdcw2025.230

[1]

Dippmann C, Schmitz M, Wunsch K, Schütze S, Beer K, Greinke C, et al. Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays. Clin Epigenet 2020;12(1):171. https://doi.org/10.1186/s13148-020-00963-w.

[2]

Leeman A, Del Pino M, Marimon L, Torné A, Ordi J, Ter Harmsel B, et al. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population. Int J Cancer 2019;144(1):160 − 8. https://doi.org/10.1002/ijc.31787.

[3]

Schmitz M, Wunsch K, Hoyer H, Scheungraber C, Runnebaum IB, Hansel A, et al. Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women. Clin Epigenet 2017;9(1):118. https://doi.org/10.1186/s13148-017-0419-2.

[4]

McMenamin M, McKenna M, McDowell A. Clinical utility of CINtec PLUS triage in equivocal cervical cytology and human papillomavirus primary screening. Am J Clin Pathol 2018;150(6):512 − 21. https://doi.org/10.1093/ajcp/aqy073.

[5]

Yue X, Duan YQ, Guo DJ, Wang YX, Wang CP, Liu X. Diagnostic accuracy of available methylation assays in advanced cervical intraepithelial neoplasia from high-risk HPV-positive women: a systematic review and network meta-analysis. Eur J Obstet Gynecol Reprod Biol 2025;308:54 − 65. https://doi.org/10.1016/j.ejogrb.2025.02.038.

[6]

Schmitz M, Eichelkraut K, Schmidt D, Zeiser I, Hilal Z, Tettenborn Z, et al. Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages. BMC Cancer 2018;18(1):1197. https://doi.org/10.1186/s12885-018-5125-8.

[7]

Cuzick J, Clavel C, Petry KU, Meijer CJLM, Hoyer H, Ratnam S, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. International Journal of Cancer. 2006;119(5):1095 − 1101 https://doi.org/10.1002/ijc.21955.

[8]

Salta S, Lobo J, Magalhães B, Henrique R, Jerónimo C. DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis. Clin Epigenet 2023;15(1):125. https://doi.org/10.1186/s13148-023-01537-2.

[9]

World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd ed. Geneva: World Health Organization. 2021. https://www.who.int/publications/i/item/9789240030824.

[10]

Shi LY, Yang X, He L, Zheng CY, Ren Z, Warsame JA, et al. Promoter hypermethylation analysis of host genes in cervical intraepithelial neoplasia and cervical cancers on histological cervical specimens. BMC Cancer 2023;23(1):168. http://dx.doi.org/10.1186/s12885-023-10628-5.

[11]

Vink FJ, Meijer CJLM, Hesselink AT, Floore AN, Lissenberg-Witte BI, Bonde JH, et al. FAM19A4/miR124-2 methylation testing and human papillomavirus (HPV) 16/18 genotyping in HPV-positive women under the age of 30 years. Clin Infect Dis 2023;76(3):e827 − 34. https://doi.org/10.1093/cid/ciac433.

[12]

Zhu P, Xiong J, Yuan D, Li X, Luo LL, Huang J, et al. ZNF671 methylation test in cervical scrapings for cervical intraepithelial neoplasia grade 3 and cervical cancer detection. Cell Rep Med 2023;4(8):101143. https://doi.org/10.1016/j.xcrm.2023.101143.